Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors.

Quartuccio L, Bond M, Isola M, Monti S, Felicetti M, Furini F, Murgia S, Berti A, Silvestri E, Pazzola G, Bozzolo E, Leccese P, Raffeiner B, Parisi S, Leccese I, Cianci F, Bettio S, Sainaghi P, Ianniello A, Ravagnani V, Bellando Randone S, Faggioli P, Lomater C, Stobbione P, Ferro F, Colaci M, Alfieri G, Carubbi F, Erre GL, Giollo A, Franzolini N, Ditto MC, Balduzzi S, Padoan R, Bortolotti R, Bortoluzzi A, Cariddi A, Padula A, Di Scala G, Gremese E, Conti F, D'Angelo S, Matucci Cerinic M, Dagna L, Emmi G, Salvarani C, Paolazzi G, Roccatello D, Govoni M, Schiavon F, Caporali R, De Vita S; Italian Study Group on Lung Involvement in Rheumatic Diseases and the Italian Vasculitis Study Group.

J Autoimmun. 2020 Jan 8:102397. doi: 10.1016/j.jaut.2019.102397. [Epub ahead of print]

PMID:
31926833
2.

Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease.

Guidi L, Pugliese D, Tonucci TP, Bertani L, Costa F, Privitera G, Tolusso B, Di Mario C, Albano E, Tapete G, Gremese E, Papa A, Gasbarrini A, Rapaccini GL, Armuzzi A.

United European Gastroenterol J. 2019 Nov;7(9):1189-1197. doi: 10.1177/2050640619873784. Epub 2019 Sep 3.

3.

Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study.

Manfredi A, Cassone G, Furini F, Gremese E, Venerito V, Atzeni F, Arrigoni E, Della Casa G, Cerri S, Govoni M, Petricca L, Iannone F, Salvarani C, Sebastiani M.

Intern Med J. 2019 Oct 29. doi: 10.1111/imj.14670. [Epub ahead of print]

PMID:
31661185
4.

Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity.

Benucci M, Grossi V, Manfredi M, Damiani A, Infantino M, Moscato P, Cinquanta L, Gremese E, Tolusso B, Petricca L, Fedele AL, Alivernini S, Atzeni F, Minisola G, Verna R.

Ann Lab Med. 2020 Mar;40(2):101-113. doi: 10.3343/alm.2020.40.2.101. Review.

5.

The B side of rheumatoid arthritis pathogenesis.

Alivernini S, Tolusso B, Fedele AL, Di Mario C, Ferraccioli G, Gremese E.

Pharmacol Res. 2019 Nov;149:104465. doi: 10.1016/j.phrs.2019.104465. Epub 2019 Sep 28. Review.

PMID:
31574298
6.

QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study.

Erre GL, Piras A, Piga M, Fedele AL, Mangoni AA, Lazzerini PE, Gremese E, Mathieu A, Ferraccioli G, Passiu G, Saba PS; EDRA study group.

Clin Exp Rheumatol. 2019 Aug 27. [Epub ahead of print]

PMID:
31498064
7.

Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers.

Zizzo G, De Santis M, Bosello S, Tolusso B, Alivernini S, De Luca G, Gremese E, Ferraccioli G.

Eur J Immunol. 2019 Dec;49(12):2195-2203. doi: 10.1002/eji.201847849. Epub 2019 Aug 22.

PMID:
31400229
8.

Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey.

Ravelli A, Sinigaglia L, Cimaz R, Alessio M, Breda L, Cattalini M, Consolaro A, Conti F, Cortis E, D'Angelo S, De Benedetti F, Doria A, Ferrari C, Gallizzi R, Govoni M, Gremese E, Iannone F, La Torre F, Maggio MC, Perricone R, Pontikaki I, Rossi F, Salaffi F, Simonini G, Caporali R; Italian Paediatric Rheumatology Study Group and the Italian Society of Rheumatology.

Clin Exp Rheumatol. 2019 Nov-Dec;37(6):1084-1091. Epub 2019 Jul 25.

PMID:
31376254
9.

Adult onset Still's disease and pregnancy.

De Carolis S, Cianci F, Del Sordo G, Garofalo S, Garufi C, Lanzone A, Zoli A, Gremese E.

Autoimmun Rev. 2019 Sep;18(9):102356. doi: 10.1016/j.autrev.2019.102356. Epub 2019 Jul 16. No abstract available.

PMID:
31323360
10.

Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis.

Alivernini S, Tolusso B, Gigante MR, Petricca L, Bui L, Fedele AL, Di Mario C, Benvenuto R, Federico F, Ferraccioli G, Gremese E.

Sci Rep. 2019 Jul 18;9(1):10420. doi: 10.1038/s41598-019-46927-w.

11.

JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy.

Gremese E, Alivernini S, Tolusso B, Zeidler MP, Ferraccioli G.

J Leukoc Biol. 2019 Nov;106(5):1063-1068. doi: 10.1002/JLB.5RU0519-145R. Epub 2019 Jul 16. Review.

12.

Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device).

Manfredi A, Cassone G, Cerri S, Venerito V, Fedele AL, Trevisani M, Furini F, Addimanda O, Pancaldi F, Della Casa G, D'Amico R, Vicini R, Sandri G, Torricelli P, Celentano I, Bortoluzzi A, Malavolta N, Meliconi R, Iannone F, Gremese E, Luppi F, Salvarani C, Sebastiani M; GISEA (Gruppo Italiano Studio Early Arthritis).

BMC Pulm Med. 2019 Jun 20;19(1):111. doi: 10.1186/s12890-019-0875-x.

13.

PsA-Disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients: an Italian derma-rheuma multicentre study.

Chimenti MS, Esposito M, Graceffa D, Teoli M, Peluso G, Birra D, Moretta G, Galossi A, Carboni V, Sensi F, Mazzotta A, Caccavale R, Bernardini N, Sessa P, Richetta A, Del Duca E, Urbani S, Persechino S, De Simone C, Bonifati C, Gremese E, Peris K, Perricone R.

Ther Adv Chronic Dis. 2019 May 14;10:2040622319847056. doi: 10.1177/2040622319847056. eCollection 2019.

14.

Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy.

Chimenti MS, Conigliaro P, Navarini L, Martina FM, Peluso G, Birra D, Sessa P, Anzidei M, Scolieri P, Bruzzese V, Santoboni G, Cardello P, Gremese E, Afeltra A, Valesini G, Sebastiani GD, Perricone R, Scrivo R.

Clin Exp Rheumatol. 2019 May 22. [Epub ahead of print]

PMID:
31140397
15.

Body mass index as a driver of selection of biologic therapy in rheumatoid arthritis. Results from the US-CLARA study.

Di Carlo M, Salaffi F, Gremese E, Iannone F, Lapadula G, Ferraccioli G; GISEA Study Group.

Eur J Intern Med. 2019 Aug;66:57-61. doi: 10.1016/j.ejim.2019.05.017. Epub 2019 May 18.

PMID:
31113709
16.

Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis.

Alivernini S, Bruno D, Tolusso B, Bui L, Petricca L, Gigante MR, Birra D, Fedele AL, Peluso G, Federico F, Ferraccioli G, Gremese E.

Arthritis Res Ther. 2019 May 9;21(1):116. doi: 10.1186/s13075-019-1898-7.

17.

Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.

Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Sota J, Cavallaro E, Massaro MG, Ruscitti P, Cipriani P, De Marchi G, De Vita S, Emmi G, Ferraccioli G, Frassi M, Gerli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Rigante D, Dagna L, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Apr 2;10:296. doi: 10.3389/fphar.2019.00296. eCollection 2019.

18.

Selective Inhibitors of T Cell Receptor Recognition of Antigen-MHC Complexes for Rheumatoid Arthritis.

Ria F, Pirolli D, Di Sante G, Righino B, Gremese E, Gervasoni J, Nicolò C, Giardina B, Ferraccioli G, De Rosa MC.

ACS Med Chem Lett. 2019 Mar 13;10(4):644-649. doi: 10.1021/acsmedchemlett.8b00601. eCollection 2019 Apr 11.

PMID:
30996811
19.

Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study.

Pugliese D, Daperno M, Fiorino G, Savarino E, Mosso E, Biancone L, Testa A, Sarpi L, Cappello M, Bodini G, Caprioli F, Festa S, Laino G, Maconi G, Mazzuoli S, Mocci G, Sartini A, D'Amore A, Alivernini S, Gremese E, Armuzzi A.

Dig Liver Dis. 2019 Jul;51(7):972-977. doi: 10.1016/j.dld.2019.03.007. Epub 2019 Apr 13.

PMID:
30992173
20.

Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease.

Chimenti MS, Caso F, Alivernini S, De Martino E, Costa L, Tolusso B, Triggianese P, Conigliaro P, Gremese E, Scarpa R, Perricone R.

Autoimmun Rev. 2019 Jun;18(6):565-575. doi: 10.1016/j.autrev.2018.11.007. Epub 2019 Apr 5. Review.

PMID:
30959209
21.

Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels.

Occhipinti M, Bosello S, Sisti LG, Cicchetti G, de Waure C, Pirronti T, Ferraccioli G, Gremese E, Larici AR.

PLoS One. 2019 Mar 12;14(3):e0213444. doi: 10.1371/journal.pone.0213444. eCollection 2019.

22.

Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease.

Alivernini S, Pugliese D, Tolusso B, Felice C, Gremese E, Armuzzi A.

Rheumatology (Oxford). 2019 Jun 1;58(6):1113-1115. doi: 10.1093/rheumatology/kez056. No abstract available.

PMID:
30847491
23.

Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA.

Atzeni F, Sarzi-Puttini P, Sebastiani M, Panetta V, Salaffi F, Iannone F, Carletto A, Foti R, Gremese E, Govoni M, Marchesoni A, Favalli E, Gorla R, Ramonda R, Ferraccioli G, Lapadula G; GISEA group.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):649-655. Epub 2019 Feb 11.

PMID:
30767865
24.

Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases.

De Lorenzis E, Gremese E, Bosello S, Nurmohamed MT, Sinagra G, Ferraccioli G.

Autoimmun Rev. 2019 Apr;18(4):317-324. doi: 10.1016/j.autrev.2019.02.002. Epub 2019 Feb 7. Review. No abstract available.

PMID:
30743079
25.

Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve.

Di Mario C, Petricca L, Gigante MR, Barini A, Barini A, Varriano V, Paglionico A, Cattani P, Ferraccioli G, Tolusso B, Gremese E.

Endocrine. 2019 Feb;63(2):405. doi: 10.1007/s12020-018-1811-1.

PMID:
30506360
26.

Statins and Mortality in Connective Tissue Diseases: Should We Resume the Cardio-rheumatology Spirit in Our Clinics?

Gremese E, DE Lorenzis E, Ferraccioli GF.

J Rheumatol. 2018 Dec;45(12):1617-1619. doi: 10.3899/jrheum.180732. No abstract available.

PMID:
30504479
27.

Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.

Bosello S, De Luca G, Berardi G, Canestrari G, de Waure C, Gabrielli FA, Di Mario C, Forni F, Gremese E, Ferraccioli G.

Eur J Intern Med. 2019 Feb;60:46-53. doi: 10.1016/j.ejim.2018.10.013. Epub 2018 Oct 23.

PMID:
30366614
28.

The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts.

Favalli EG, Becciolini A, Caporali R, Todoerti M, Iannone F, Dinoia L, Sebastiani M, Spinella A, Gremese E, Cianci F, Atzeni F, Bandinelli F, Ferraccioli G, Lapadula G; GISEA Study Group.

Autoimmun Rev. 2018 Dec;17(12):1251-1258. doi: 10.1016/j.autrev.2018.07.002. Epub 2018 Oct 16. Review.

PMID:
30339886
29.

Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve.

Di Mario C, Petricca L, Gigante MR, Barini A, Barini A, Varriano V, Paglionico A, Cattani P, Ferraccioli G, Tolusso B, Gremese E.

Endocrine. 2019 Feb;63(2):369-375. doi: 10.1007/s12020-018-1783-1. Epub 2018 Oct 15. Erratum in: Endocrine. 2018 Dec 1;:.

PMID:
30324323
30.

Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus.

Todoerti M, Favalli EG, Iannone F, Olivieri I, Benucci M, Cauli A, Mathieu A, Santo L, Minisola G, Lapadula G, Bucci R, Gremese E, Caporali R.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii42-vii53. doi: 10.1093/rheumatology/key195. Review.

31.

The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference.

Conti F, Atzeni F, Massaro L, Chiara Gerardi M, Gremese E, Passiu G, Carletto A, Malavolta N, Foti R, Ramonda R, Sarzi-Puttini P.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii11-vii22. doi: 10.1093/rheumatology/key209. Review.

PMID:
30289537
32.

Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.

Frasca L, Palazzo R, Chimenti MS, Alivernini S, Tolusso B, Bui L, Botti E, Giunta A, Bianchi L, Petricca L, Auteri SE, Spadaro F, Fonti GL, Falchi M, Evangelista A, Marinari B, Pietraforte I, Spinelli FR, Colasanti T, Alessandri C, Conti F, Gremese E, Costanzo A, Valesini G, Perricone R, Lande R.

Front Immunol. 2018 Sep 12;9:1936. doi: 10.3389/fimmu.2018.01936. eCollection 2018.

33.

Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis.

Tolusso B, Gigante MR, Alivernini S, Petricca L, Fedele AL, Di Mario C, Aquilanti B, Magurano MR, Ferraccioli G, Gremese E.

Front Med (Lausanne). 2018 Aug 3;5:207. doi: 10.3389/fmed.2018.00207. eCollection 2018.

34.

Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features.

Alivernini S, Tolusso B, Petricca L, Bui L, Di Mario C, Gigante MR, Di Sante G, Benvenuto R, Fedele AL, Federico F, Ferraccioli G, Gremese E.

Front Med (Lausanne). 2018 Jul 3;5:186. doi: 10.3389/fmed.2018.00186. eCollection 2018.

35.

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.

Guidi L, Pugliese D, Tonucci TP, Berrino A, Tolusso B, Basile M, Cantoro L, Balestrieri P, Civitelli F, Bertani L, Marzo M, Felice C, Gremese E, Costa F, Viola F, Cicala M, Kohn A, Gasbarrini A, Rapaccini GL, Ruggeri M, Armuzzi A.

J Crohns Colitis. 2018 Aug 29;12(9):1079-1088. doi: 10.1093/ecco-jcc/jjy076.

PMID:
29860436
36.

Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs.

Gremese E, Fedele AL, Alivernini S, Ferraccioli G.

Ann Rheum Dis. 2018 Oct;77(10):1391-1393. doi: 10.1136/annrheumdis-2018-212941. Epub 2018 Jun 2. No abstract available.

37.

Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles of the responders.

Zizzo G, Gremese E, Ferraccioli G.

Immunotherapy. 2018 Jul;10(9):807-821. doi: 10.2217/imt-2018-0014. Epub 2018 May 8. Review.

PMID:
29737909
38.

Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression.

Bosello S, Angelucci C, Lama G, Alivernini S, Proietti G, Tolusso B, Sica G, Gremese E, Ferraccioli G.

Arthritis Res Ther. 2018 Apr 18;20(1):75. doi: 10.1186/s13075-018-1569-0.

39.

Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.

Alivernini S, Pugliese D, Tolusso B, Bui L, Petricca L, Guidi L, Mirone L, Rapaccini GL, Federico F, Ferraccioli G, Armuzzi A, Gremese E.

RMD Open. 2018 Apr 9;4(1):e000667. doi: 10.1136/rmdopen-2018-000667. eCollection 2018.

40.

Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of "benign autoimmunity "to the concept of" autoimmunity as a red flag in preventive medicine"?

Ferraccioli G, Alivernini S, Tolusso B, Gremese E.

Autoimmun Rev. 2018 Jun;17(6):636-638. doi: 10.1016/j.autrev.2018.01.013. Epub 2018 Apr 8. No abstract available.

PMID:
29641988
41.

Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy.

Fedele AL, Petricca L, Tolusso B, Alivernini S, Canestri S, Di Mario C, Bosello SL, Ferraccioli G, Gremese E.

Scand J Rheumatol. 2018 Sep;47(5):351-359. doi: 10.1080/03009742.2017.1416668. Epub 2018 Mar 15.

PMID:
29542372
42.

Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study.

Erre GL, Piga M, Fedele AL, Mura S, Piras A, Cadoni ML, Cangemi I, Dessi M, Di Sante G, Tolusso B, Gremese E, Cauli A, Mangoni AA, Saba PS, Carru C, Ferraccioli G, Mathieu A, Passiu G.

Mediators Inflamm. 2018 Feb 1;2018:6548715. doi: 10.1155/2018/6548715. eCollection 2018.

43.

Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu.

Bosello S, Basile U, De Lorenzis E, Gulli F, Canestrari G, Napodano C, Parisi F, Pocino K, Di Mario C, Tolusso B, Ferraccioli G, Gremese E.

J Clin Pathol. 2018 Jul;71(7):620-625. doi: 10.1136/jclinpath-2017-204656. Epub 2018 Jan 31.

PMID:
29447111
44.

MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis.

Alivernini S, Gremese E, McSharry C, Tolusso B, Ferraccioli G, McInnes IB, Kurowska-Stolarska M.

Front Immunol. 2018 Jan 5;8:1932. doi: 10.3389/fimmu.2017.01932. eCollection 2017. Review.

45.

Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells.

Alivernini S, Tolusso B, Ferraccioli G, Gremese E, Kurowska-Stolarska M, McInnes IB.

Clin Exp Immunol. 2018 Jul;193(1):13-23. doi: 10.1111/cei.13098. Epub 2018 Feb 2. Review.

46.

The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis.

Biscetti F, Flex A, Alivernini S, Tolusso B, Gremese E, Ferraccioli G.

Mediators Inflamm. 2017;2017:5230374. doi: 10.1155/2017/5230374. Epub 2017 Oct 23. Review.

47.

The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis.

Salaffi F, Di Carlo M, Iannone F, Fedele AL, Epis OM, Pellerito R, Foti R, Passiu G, Punzi L, Furini F, Sarzi-Puttini P, Carletto A, Gremese E, Lapadula G, Ferraccioli G.

Semin Arthritis Rheum. 2018 Apr;47(5):619-629. doi: 10.1016/j.semarthrit.2017.09.013. Epub 2017 Sep 28.

PMID:
29102157
48.

Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.

Iannone F, Ferraccioli G, Sinigaglia L, Favalli EG, Sarzi-Puttini P, Atzeni F, Gorla R, Bazzani C, Govoni M, Farina I, Gremese E, Carletto A, Giollo A, Galeazzi M, Foti R, Bianchino L, La Grasta L, Lapadula G.

Clin Rheumatol. 2018 Feb;37(2):315-321. doi: 10.1007/s10067-017-3846-8. Epub 2017 Oct 5.

PMID:
28980085
49.

Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons.

Alivernini S, Galeazzi M, Peleg H, Tolusso B, Gremese E, Ferraccioli G, Naparstek Y.

Autoimmun Rev. 2017 Nov;16(11):1096-1102. doi: 10.1016/j.autrev.2017.09.002. Epub 2017 Sep 9. Review.

PMID:
28899798
50.

Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugs.

Atzeni F, Carletto A, Foti R, Sebastiani M, Panetta V, Salaffi F, Bonitta G, Iannone F, Gremese E, Govoni M, Marchesoni A, Favalli EG, Gorla R, Ramonda R, Sarzi-Puttini P, Ferraccioli G, Lapadula G; GISEA group.

Joint Bone Spine. 2018 Jul;85(4):455-459. doi: 10.1016/j.jbspin.2017.08.003. Epub 2017 Sep 8.

PMID:
28893679

Supplemental Content

Loading ...
Support Center